U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C19H15F6N3O3S
Molecular Weight 479.396
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of A-784168

SMILES

FC(F)(F)C1=CC=CN=C1N2CCC(=CC2)C(=O)NC3=CC=C(C=C3)S(=O)(=O)C(F)(F)F

InChI

InChIKey=SDUAWRFBHRAFBM-UHFFFAOYSA-N
InChI=1S/C19H15F6N3O3S/c20-18(21,22)15-2-1-9-26-16(15)28-10-7-12(8-11-28)17(29)27-13-3-5-14(6-4-13)32(30,31)19(23,24)25/h1-7,9H,8,10-11H2,(H,27,29)

HIDE SMILES / InChI

Molecular Formula C19H15F6N3O3S
Molecular Weight 479.396
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

A-784168 is a potent and selective antagonist of Vanilloid receptor type 1 (TRPV1). A-784168 has a good CNS penetration. Significant CNS penetration is necessary for a TRPV1 antagonist to produce broad-spectrum analgesia that was shown on animal models after oral administration of this compound.

CNS Activity

Curator's Comment: Known to be CNS penetrant in rats. Human data not available

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
25.0 nM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists.
2006 Sep 13
Patents

Sample Use Guides

rats: For oral administration, A-784168 in 10% dehydrated ethanol, 20% polysorbate 80, and 70% polyethylene glycol 400 (PEG) was administered 1 h before testing using a volume of 2 ml/kg. For intrathecal administration, compound was dissolved in 10% di-methyl-sulfoxide/90% hydroxyl-β-cyclodextrin, injected in a volume of 10 μl, and followed by a 10 μl saline flush
Route of Administration: Other
A-784168 was identified as TRPV1 antagonists in a capsaicin-induced calcium flux assay using a fluorometric imaging plate reader. Concentration-effect curves for capsaicin-induced, increased intracellular Ca2+ in the presence of increasing concentrations of A-784168 (0-200 nM). A-784168 potently and competitively inhibited capsaicin-induced calcium flux into 1321N1 astrocytoma cells expressing recombinant human TRPV1. The IC50 value for inhibiting TRPV1 activation by 50 nM capsaicin was 25.0 nM. A-784168 inhibited pH 5.5-induced activation of recombinant TRPV1 expressed in HEK293 cells with similar potency IC50 = 14.0 ± 2.3 as well as activation by 3 μM NADA (IC50 = 33.7 ± 9.6) and 10 μM anandamide (IC50 = 35.1 ± 10.6). It also blocked 1 μM capsaicin-induced currents in rat dorsal root ganglion neurons using electrophysiologic methods (IC50 = 10 nM)
Substance Class Chemical
Created
by admin
on Sat Dec 16 10:04:30 GMT 2023
Edited
by admin
on Sat Dec 16 10:04:30 GMT 2023
Record UNII
LB160J37HD
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
A-784168
Common Name English
(1(2H),2'-BIPYRIDINE)-4-CARBOXAMIDE, 3,6-DIHYDRO-3'-(TRIFLUOROMETHYL)-N-(4-((TRIFLUOROMETHYL)SULFONYL)PHENYL)-
Systematic Name English
Code System Code Type Description
PUBCHEM
11420211
Created by admin on Sat Dec 16 10:04:30 GMT 2023 , Edited by admin on Sat Dec 16 10:04:30 GMT 2023
PRIMARY
CAS
824982-41-4
Created by admin on Sat Dec 16 10:04:30 GMT 2023 , Edited by admin on Sat Dec 16 10:04:30 GMT 2023
PRIMARY
FDA UNII
LB160J37HD
Created by admin on Sat Dec 16 10:04:30 GMT 2023 , Edited by admin on Sat Dec 16 10:04:30 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY